<DOC>
	<DOC>NCT01806935</DOC>
	<brief_summary>The purpose of the study is to assess the the effect of the study product on itching symptoms associated with xerotic dermatitis in aged population</brief_summary>
	<brief_title>Xerotic Dermatitis in Aged People</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<criteria>Aged from 70 years With xerotic dermatitis, clinically assessed , At least on the anterior part of lower and/or upper limbs, Presenting itching xerotic dermatitis evolving from at least 3 weeks Intensity of itching ≥ 4 on VAS (010) at th inclusion time With MMSE score ≥ 20 dating less than 6 months Affiliated to a social security system, or is a beneficiary (as applicable in the national regulation) Criteria related to pathologies Severe form of other dermatitis requiring either systemic treatment Itching xerotic dermatitis from iatrogenic origins Dermatological disease other than xerotic dermatitis which could interfere with the assessment, Systemic disease that may generate xerotic dermatitis and /or pruritus Immunosuppression condition, History of serious disease considered by the investigator hazardous for the patient or incompatible with the study. Criteria related to treatment Use of treatment which could interfere with the evaluation of the disease or the course of the disease Criteria related to the population Ongoing participation to another clinical trial or participation in the previous month before the inclusion Patient under guardianship or trusteeship</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>associated</keyword>
	<keyword>aged population</keyword>
</DOC>